← Back to Patent Explorer
US3692895A Expired / Lapsed US ⏱️ 0.0 years remaining

Method of reducing hypercholesteremia in humans employing a copolymer of polyethylenepolyamine and a bifunctional substance, such as epichlorohydria

Assignee: GARY E VANDENBERG
•
Filing: 1970-09-08
•
Granted: 1972-09-19
•
Expires: 1990-09-08
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Compositions and processes are provided for lowering hypercholesteremia in mammals and birds. Oral administration to affected mammals and birds supplies an effective amount of a cholesterol-lowering substance. The cholesterol-lowering substance is a nontoxic cross-linked copolymer of a polyethylenepolyamine and a bifunctional substance containing halogen atoms and/or epoxy groups.

Inventors

  • 👤 Norman A Nelson
  • 👤 Gary E Vandenberg

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-02 09:15
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/74; A61K31/785

Claims Analysis

Total Claims: 7
Claim 1
Independent Claim 16 words
The method of claim 1 wherein the polyethylenepolyamine is tetraethylenepentaMine and the second member is epichlorohydrin.
Claim 2
Dependent Claim 18 words
The method of claim 1 wherein the cross-linked copolymer is administered in the form of an aqueous dispersion.
Claim 3
Dependent Claim 17 words
The method of claim 1 wherein the polyethylenepolyamine is diethylene triamine and the second member is epichlorohydrin.
Claim 4
Dependent Claim 10 words
The method of claim 1 wherein the polyethylenepolyamine is triethylenetetramine.
Claim 5
Dependent Claim 11 words
The method of claim 1 wherein the second member is epichlorohydrin.
Claim 6
Dependent Claim 15 words
The method of claim 1 which includes tocamphyl or florantyrone as an additional active ingredient.
Claim 7
Dependent Claim 13 words
The method of claim 1 which includes clofibrate as an additional active ingredient.

References Cited (Backward Citations)

GB628821A Cited
US2644760A Cited
GB860303A Cited
US3152188A Cited
US3308020A Cited
US3383281A Cited
US3332841A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1975-09-19 1976-03-20 1976-09-19 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1979-09-19 1980-03-20 1980-09-19 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1983-09-19 1984-03-20 1984-09-19 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag